BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260516
DTSTAMP:20260526T033905
CREATED:20251206T101044Z
LAST-MODIFIED:20251206T101044Z
UID:9623-1778457600-1778889599@thebiocalendar.com
SUMMARY:ASGCT Annual Meeting
DESCRIPTION:The ASGCT Annual Meeting is the leading global event for professionals in gene and cell therapy\, hosted by the American Society of Gene + Cell Therapy (ASGCT) to showcase cutting-edge research\, new technologies\, and clinical applications\, offering crucial networking for scientists\, industry leaders\, and clinicians to advance treatments for human diseases. It features expert presentations\, novel abstract presentations\, workshops\, and exhibitions from companies in the cell and gene therapy ecosystem.
URL:https://thebiocalendar.com/event/asgct-annual-meeting/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Academic Research,Networking,Presentation
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260516
DTSTAMP:20260526T033905
CREATED:20251206T101440Z
LAST-MODIFIED:20260116T121409Z
UID:9625-1778457600-1778889599@thebiocalendar.com
SUMMARY:PEGS Boston
DESCRIPTION:The PEGS Boston Summit is where the future of biologics takes shape. For over 20 years\, PEGS is the go-to event for protein and antibody engineering\, drug development\, immunotherapy\, radiotherapy\, and AI/ML-driven biologics research. New in 2026: a dedicated focus on peptides\, spotlighting their therapeutic power\, design innovations\, and expanding role in drug discovery. \nWith 350+ presentations\, breakout sessions\, and interactive training seminars\, PEGS delivers the insights and connections you need to stay ahead. The exhibit hall buzzes with top technology and service providers\, giving you a front-row seat to the tools transforming the industry. \nDon’t just follow the science – be part of it. Join us at the 2026 PEGS Boston Summit and connect with the leaders shaping what’s next in biologics and beyond.
URL:https://thebiocalendar.com/event/pegs-boston-3/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Featured,Summit
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/12/pegs2026-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260511T080000
DTEND;TZID=America/Los_Angeles:20260514T170000
DTSTAMP:20260526T033905
CREATED:20251206T100827Z
LAST-MODIFIED:20251206T100827Z
UID:9622-1778486400-1778778000@thebiocalendar.com
SUMMARY:AAPS National Biotechnology Conference
DESCRIPTION:The AAPS National Biotechnology Conference (NBC) is a premier annual event by the American Association of Pharmaceutical Scientists (AAPS) for leaders in pharma and biotech to explore cutting-edge science in biologics\, advanced therapies\, and innovative drug development\, focusing on new modalities like CAR-T\, gene therapies\, and AI in drug discovery\, bridging research from lab to patient. It features scientific sessions\, poster presentations\, and networking opportunities\, addressing challenges in formulation\, bioanalysis\, manufacturing\, and translational science for complex drugs
URL:https://thebiocalendar.com/event/aaps-national-biotechnology-conference/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Academic Research,Summit,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260511T110000
DTEND;TZID=America/Los_Angeles:20260511T120000
DTSTAMP:20260526T033905
CREATED:20260410T130948Z
LAST-MODIFIED:20260410T130948Z
UID:10185-1778497200-1778500800@thebiocalendar.com
SUMMARY:Design scalable downstream processes with practical purification and analytical strategies
DESCRIPTION:Downstream process development is rapidly evolving as new modalities\, from mAbs to mRNA\, viral vectors\, and other complex molecules\, enter development pipelines. This webinar will share practical strategies and analytical considerations for designing robust\, scalable purification processes across diverse molecule types. \nDrawing on decades of chromatography innovation and the expertise of our global Fast Trak™ process development (PD) teams\, Cytiva speakers will show how we use tools such as our Biacore™ surface plasmon resonance (SPR) system and size-exclusion chromatography with multi-angle light scattering (SEC-MALS) to clarify complex mechanisms\, address unpredictable impurities\, and overcome challenges that traditional approaches cannot resolve. \nYou will also hear how the combination of this experience\, advanced analytics\, and focused knowledge transfer can accelerate development\, reduce risk\, and help customers build lasting internal capability and true process ownership. \nUsing case examples spanning proteins\, antibodies\, nucleic acids\, viruses\, and vesicles\, we will feature common downstream pitfalls and highlight how our integrated chromatography and analytical strengths help avoid them. Whether you are advancing proof of concept or preparing to scale up\, you will leave with a clear view of how Cytiva PD\, SPR\, and chromatography leadership enables efficient\, confident downstream development—even for the most complex modalities. \nKey Learning Objectives: \n    Learn practical\, scalable approaches for developing chromatography‑based purification processes\n    Understand how advanced analytical tools such as SPR (Biacore™ system) and SEC‑MALS reveal complex molecular interactions and impurity mechanisms\n    Explore how combining chromatography expertise\, advanced analytics\, and structured knowledge transfer accelerates development and builds long‑term process capability
URL:https://thebiocalendar.com/event/design-scalable-downstream-processes-with-practical-purification-and-analytical-strategies/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-11-26-Cytiva-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260511T110000
DTEND;TZID=America/Los_Angeles:20260511T120000
DTSTAMP:20260526T033905
CREATED:20260429T123417Z
LAST-MODIFIED:20260429T123417Z
UID:10276-1778497200-1778500800@thebiocalendar.com
SUMMARY:ADC Outsourcing: Plan Smart Now or Suffer Later
DESCRIPTION:Antibody-drug conjugates (ADCs) bring together multiple scientific and operational disciplines\, which makes early and ongoing outsourcing decisions especially consequential. This event examines how sponsors think through outsourcing strategies across discovery support\, process development\, bioconjugation\, analytical work\, drug substance\, and fill-finish\, focusing on what should remain internal and what should be outsourced to external partners. Our panel will discuss how to evaluate capabilities\, sequence development activities\, avoid fragmentation across vendors\, and build an outsourcing plan that supports speed without creating unnecessary technical or program risk.
URL:https://thebiocalendar.com/event/adc-outsourcing-plan-smart-now-or-suffer-later/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/Biocal-15.png
END:VEVENT
END:VCALENDAR